169 related articles for article (PubMed ID: 36835134)
1. Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans.
Qiu C; Ma Y; Wang B; Zhang X; Wang X; Zhang JY
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835134
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
Ma Y; Qiu C; Wang B; Zhang X; Wang X; Aguilera RJ; Zhang JY
Cells; 2022 Oct; 11(20):. PubMed ID: 36291095
[TBL] [Abstract][Full Text] [Related]
3. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.
Shao Q; Ren P; Li Y; Peng B; Dai L; Lei N; Yao W; Zhao G; Li L; Zhang J
Int J Oncol; 2012 Sep; 41(3):1061-7. PubMed ID: 22692946
[TBL] [Abstract][Full Text] [Related]
5. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
[TBL] [Abstract][Full Text] [Related]
6. A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
Liu M; Liu X; Ren P; Li J; Chai Y; Zheng SJ; Chen Y; Duan ZP; Li N; Zhang JY
Tumour Biol; 2014 May; 35(5):4247-56. PubMed ID: 24390614
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.
Liu M; Zheng SJ; Chen Y; Li N; Ren PF; Dai LP; Duan ZP; Zhang JY
J Immunol Res; 2014; 2014():906532. PubMed ID: 24955377
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma.
Ying X; Han SX; He CC; Zhou CY; Dong YP; Cai MJ; Sui X; Ma CX; Sun X; Zhang YY; Gou WL; Mason C; Zhu Q
Oncotarget; 2017 Apr; 8(15):24828-24839. PubMed ID: 28186997
[TBL] [Abstract][Full Text] [Related]
9. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
[TBL] [Abstract][Full Text] [Related]
10. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
Chen Y; Zhou Y; Qiu S; Wang K; Liu S; Peng XX; Li J; Tan EM; Zhang JY
Cancer Lett; 2010 Mar; 289(1):32-9. PubMed ID: 19683863
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
[TBL] [Abstract][Full Text] [Related]
13. Integration of IgG and IgA autoantibodies for early diagnosis of hepatocellular carcinoma.
Yang T; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Qiu F; Huang Y
Clin Chim Acta; 2021 Dec; 523():423-429. PubMed ID: 34728178
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.
Zhou JW; Li Y; Yue LX; Luo CL; Chen Y; Zhang JY
Tumour Biol; 2016 Feb; 37(2):2547-53. PubMed ID: 26386724
[TBL] [Abstract][Full Text] [Related]
15. Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma.
Yang Q; Ye H; Sun G; Wang K; Dai L; Qiu C; Shi J; Zhu J; Wang X; Wang P
Mol Oncol; 2023 May; 17(5):887-900. PubMed ID: 36587394
[TBL] [Abstract][Full Text] [Related]
16. Serum autoantibody measurement for the detection of hepatocellular carcinoma.
Middleton CH; Irving W; Robertson JF; Murray A; Parsy-Kowalska CB; Macdonald IK; McElveen J; Allen J; Healey GF; Thomson BJ; Ryder SJ; Holdenrieder S; Chapman CJ
PLoS One; 2014; 9(8):e103867. PubMed ID: 25093332
[TBL] [Abstract][Full Text] [Related]
17. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.
Koziol JA; Imai H; Dai L; Zhang JY; Tan EM
Cancer Immunol Immunother; 2018 May; 67(5):835-841. PubMed ID: 29497780
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody recognition of an N-terminal epitope of hnRNP L marks the risk for developing HBV-related hepatocellular carcinoma.
Yau WY; Shih HC; Tsai MH; Sheu JC; Chen CH; Chow LP
J Proteomics; 2013 Dec; 94():346-58. PubMed ID: 24125732
[TBL] [Abstract][Full Text] [Related]
19. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
